Literature DB >> 26823829

Association of MMP-2 expression and prognosis in osteosarcoma patients.

Miao Zhang1, Xuran Zhang1.   

Abstract

OBJECTIVE: Our aim was to investigate the MMP-2 expression and its prognostic value in osteosarcoma patients.
METHODS: We performed RT-qPCR to detect the expression of MMP-2 in 45 paired osteosarcoma tissues and adjacent noncancerous tissues. Immunohistochemical staining assay was used to verify the expression of MMP-2 protein in osteosarcoma patients. Independent-sample T test was used to analyze the difference of MMP-2 expression level between osteosarcoma and control groups. The relationship between clinicopathologic factors and MMP-2 expression was analyzed by chi-square test. Kaplan-Meier was performed to analyze the association of MMP-2 expression and overall survival rate. The prognostic value of clinicopathologic factors and MMP-2 was estimated via Cox regression analysis.
RESULTS: RT-qPCR revealed that the expression of MMP-2 was up-regulated in osteosarcoma group compared with the control group. Besides MMP-2 expression was influenced by pulmonary metastasis (P<0.05) while gender, age, tumor site and Enneking stage showed no obvious impact (P>0.05). Kaplan-Meier curve revealed that patients with positive MMP-2 expression had a shorter survival time than those with negative MMP-2 expression, and the survival rates were 18.5% (5/27) and 44.4% (8/18), respectively. Cox regression analysis indicated that pulmonary metastasis and expression of MMP-2 gene were important factors in the prognosis of osteosarcoma.
CONCLUSION: The expression of MMP-2 was associated with pulmonary metastasis, and was related to the prognosis of osteosarcoma. MMP-2 could act as an independent prognostic marker in osteosarcoma patients.

Entities:  

Keywords:  MMP-2; osteosarcoma; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26823829      PMCID: PMC4713615     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

Review 1.  Historical, current and future aspects of osteosarcoma treatment.

Authors:  S J Ham; H Schraffordt Koops; W T van der Graaf; J R van Horn; L Postma; H J Hoekstra
Journal:  Eur J Surg Oncol       Date:  1998-12       Impact factor: 4.424

2.  miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.

Authors:  Lei Chen; Qing Wang; Guo-dong Wang; Hua-song Wang; Yong Huang; Xi-ming Liu; Xian-hua Cai
Journal:  FEBS Lett       Date:  2013-03-15       Impact factor: 4.124

3.  Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways.

Authors:  Ching-Lung Liao; Kuang-Chi Lai; An-Cheng Huang; Jai-Sing Yang; Jen-Jyh Lin; Shin-Hwar Wu; W Gibson Wood; Jaung-Geng Lin; Jing-Gung Chung
Journal:  Food Chem Toxicol       Date:  2012-02-25       Impact factor: 6.023

4.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

5.  The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Authors:  J Oh; R Takahashi; S Kondo; A Mizoguchi; E Adachi; R M Sasahara; S Nishimura; Y Imamura; H Kitayama; D B Alexander; C Ide; T P Horan; T Arakawa; H Yoshida; S Nishikawa; Y Itoh; M Seiki; S Itohara; C Takahashi; M Noda
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

6.  Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.

Authors:  G Saeter; T A Alvegård; I Elomaa; A E Stenwig; T Holmström; O P Solheim
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

7.  Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.

Authors:  Ilkyu Han; Mi Ra Lee; Kwang Woo Nam; Joo Han Oh; Kyung Chul Moon; Han-Soo Kim
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

8.  A system for the surgical staging of musculoskeletal sarcoma. 1980.

Authors:  William F Enneking; Suzanne S Spanier; Mark A Goodman
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

9.  Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases.

Authors:  A H Aljubran; A Griffin; M Pintilie; M Blackstein
Journal:  Ann Oncol       Date:  2009-01-19       Impact factor: 32.976

Review 10.  Prognostic factors in osteosarcoma: a critical review.

Authors:  A M Davis; R S Bell; P J Goodwin
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

View more
  16 in total

Review 1.  Therapeutic applications of histone deacetylase inhibitors in sarcoma.

Authors:  Fan Tang; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Treat Rev       Date:  2017-07-06       Impact factor: 12.111

Review 2.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

3.  Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.

Authors:  Chen Gong; Kai Sun; Hui-Hua Xiong; Tal Sneh; Jing Zhang; Xiao Zhou; Peng Yan; Jian-Hua Wang
Journal:  Histol Histopathol       Date:  2020-04-21       Impact factor: 2.303

4.  Casein kinase 1 (CK1) promotes the proliferation and metastasis of glioma cells via the phosphatidylinositol 3 kinase-matrix metalloproteinase 2 (AKT-MMP2) pathway.

Authors:  Hua-Song Gao; She-Yu Lin; Xi Han; Hong-Zhi Xu; Yi-Lu Gao; Zhi-Yong Qin
Journal:  Ann Transl Med       Date:  2021-04

5.  Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties.

Authors:  Juan Tornín; Aranzazu Villasante; Xavi Solé-Martí; Maria-Pau Ginebra; Cristina Canal
Journal:  Free Radic Biol Med       Date:  2021-01-02       Impact factor: 7.376

6.  pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.

Authors:  Kamolrat Thanapprapasr; Adisak Nartthanarung; Duangmani Thanapprapasr; Artit Jinawath
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

7.  Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes.

Authors:  Viviane Seba; Gabriel Silva; Mariana Bastos Dos Santos; Seung Joon Baek; Suzelei de Castro França; Ana Lúcia Fachin; Luis Octavio Regasini; Mozart Marins
Journal:  Int J Mol Sci       Date:  2018-09-19       Impact factor: 5.923

Review 8.  The Tumor Microenvironment of Pediatric Sarcoma: Mesenchymal Mechanisms Regulating Cell Migration and Metastasis.

Authors:  Monika Ehnman; Wiem Chaabane; Felix Haglund; Panagiotis Tsagkozis
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 9.  Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.

Authors:  Franck Verrecchia; Françoise Rédini
Journal:  Front Oncol       Date:  2018-04-30       Impact factor: 6.244

Review 10.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.